Your Organization NameRetrieving contract details... Hang tight!
Effective Date
Apr 10, 2024
Expiration Date
Sep 30, 2031
| Description | Buyer | Seller | Issued Date | Quantity | Unit Price | Annual Fee |
|---|---|---|---|---|---|---|
| Office of Acquisition Managementt Policy | START2 GROUP, INC. | Apr 10, 2024 | 1 |
Office of Acquisition Managementt Policy
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEVELOP AND COMMERCIALIZE A RAPID PHENOTYPIC ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) SYSTEM THAT WILL DELIVER RESULTS FOR DEFINITIVE THERAPEUTIC DECISIONS WITHIN 4 TO 6 HOURS FROM COLONIES ON A CULTURE
Office of Acquisition Managementt Policy
CURIEDX - RESEARCH AND DEVELOPMENT FOR AOI #17 - TRANSFORMING RESPIRATORY INFECTION SURVEILLANCE WITH COMPUTER VISION ON A SMARTPHONE
Office of Acquisition Managementt Policy
THE OVERALL OBJECTIVE OF THIS SOW IS TO CREATE A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, DUKE UNIVERSITY ON BEHALF OF DUKE CLINICAL RESEARCH INSTITUTE (DCRI), AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATI